Helix Biopharm opened trading today at $0.17 and closed at $0.18. Intraday prices ranged from a low of $0.17 to a high of $0.18.

Shares advanced 2.78% from the previous day's close of $0.18.

During the day across North America, the TSX Composite closed -0.27% at 22051.79, the S&P 500 closed -1.23% at 5147.21, the Dow Jones Industrial Average closed -1.35% at 38596.98 and the Nasdaq Composite closed -1.40% at 16049.08.

Helix Biopharm traded under HBP on the Toronto Stock Exchange (TSX).

A total of 4,795 shares was traded during the session, with total trades of 5, with an average volume of 15,762 over the last 5 days.

The TSX market on the whole today saw 2,800 price advancers against 2,386 declines and 147 unchanged.

During the prior 52 weeks, HBP.TO has traded as high as $0.26 (October 11,2023) and low as $0.15 (October 19,2023). Moreover, in the last 52 weeks, Helix Biopharm's shares have lost -15.91 percent, while this year, they have dipped -11.90%.

Following today's trading, Helix Biopharm has a market capitalization of $39.00 million on a float of 216,674 shares outstanding. Its annual EPS is $-0.03.

Helix Biopharm is a None company headquartered in Toronto, CAN.

Currently, Helix Biopharm's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..